This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Stocks Ripping Higher on Big Volume

Amarin

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Amarin (AMRN) is a late-stage biopharmaceutical company with expertise in lipid science focused on the treatment of cardiovascular disease. This stock is trading up 3.6% at $14.98 in recent trading.

Today's Volume: 5.3 million

Average Volume: 4.5 million

Volume % Change: 104%

Shares of AMRN are spiking higher as traders jump into the stock ahead of its highly anticipated date with the FDA on Thursday July 26. Amarin will go in front of the FDA for approval of its prescription fish-oil pill AMR101 for the treatment of patients with very high levels of triglycerides.

>>Hot Biotech Stocks Traded by Hedge Funds

From a technical perspective, AMRN is ripping higher here with above average volume. This move is quickly pushing AMRN within range of triggering a near-term breakout trade. That trade will hit once AMRN takes out some near-term overhead resistance at $15.40 with high-volume.

Traders should look for long-biased if AMRN can sustain a move or close over $15.40 with volume that's near or above 4.5 million shares. At last check, AMRN has hit an intraday high of $15.15 and volume is well above its three-month average action. If we get that breakout soon, then AMRN could trade up towards $20 ahead of its FDA event.

Amarin was also featured recently in " 5 Big Stocks Ready to Slingshot Higher."
4 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AMRN $2.13 -1.40%
ALGN $60.39 -0.97%
BMRN $144.22 -0.07%
THRX $15.98 3.40%
AAPL $123.24 0.38%

Markets

Chart of I:DJI
DOW 17,549.99 +109.40 0.63%
S&P 500 2,078.79 +11.15 0.54%
NASDAQ 5,051.51 +11.7340 0.23%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs